Back to Results
First PageMeta Content
Biology / Medicine / Biotechnology / Specialty drugs / Peptide hormones / Recombinant proteins / Eli Lilly and Company / Trastuzumab / Kiran Mazumdar-Shaw / Biosimilar / Biocon / Biopharmaceutical


Biocon Limited: Q1 FY17 Earnings Call Transcript July 22, 2016 Participants from Biocon’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and Managing Director Arun Chandravarkar: CEO & Jt. Managing Director
Add to Reading List

Document Date: 2016-08-03 03:39:33


Open Document

File Size: 99,85 KB

Share Result on Facebook